#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 62

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Tuberous sclerosis complex+2

Not recruiting

Registered drugNo placebo

Study on Cannabidiol Oral Solution for Infants with Tuberous Sclerosis, Dravet Syndrome, or Lennox-Gastaut Syndrome Experiencing Uncontrolled Seizures

Registered drugNo placebo

Italy

Participants:0–17 years
Substances:Cannabidiol

Contact Research Centre

Hypertrophic cardiomyopathy

Not recruiting

Registered drug

Study Comparing Aficamten and Metoprolol for Adults with Symptomatic Hypertrophic Cardiomyopathy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Aficamten

Contact Research Centre

Small cell lung cancer limited stage

Not recruiting

Registered drug

Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

COVID-19

Not recruiting

InvestigationalNo placebo

Study of GS-5245 for Treating COVID-19 in Children and Adolescents

InvestigationalNo placebo

Italy

Participants:0–17 years
Substances:Gs-5245

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drugNo placebo

Study Comparing Pembrolizumab and Chemotherapy for Patients with Advanced or Recurrent Endometrial Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

InvestigationalNo placebo

Study of NMS-03592088 for Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Nms-03592088

Contact Research Centre

Adenocarcinoma of colon

Not recruiting

Registered drugNo placebo

Study on Holmium-166 TARE and Maintenance Therapy with Capecitabine, Bevacizumab, and Drug Combination for Patients with Unresectable Liver-Colorectal Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

Registered drug

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Registered drug

Italy

Participants:0–17 years · 18–64 years

Contact Research Centre

Migraine+2

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Atogepant

Contact Research Centre

Cystic fibrosis

Not recruiting

Investigational

Study on the Effects of Inhaled ETD001 for People with Cystic Fibrosis

Investigational

Italy

Participants:18–64 years
Substances:3-Amino-N-{[5-[4-[Bis[(2S,3R,4R,5R)-2,3,4,5,6-Pentahydroxyhexyl]Amino]Piperidine-1-Carbonyl]-1,3-Diethyl-Benzimidazol-1-Ium-2-Yl]Methyl}-5H-Pyrrolo[2,3-B]Pyrazine-2-Carboxamide Dihydrochloride Chloride

Contact Research Centre

Hypoparathyroidism

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Alfacalcidol

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Lanreotide

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.